To validate the bioinformatics findings, in vivo experiments conducted on gastric cancer cells demonstrated the role of NFE2L3 as an oncogene, facilitating the proliferation and movement of gastric cancer cells. This evidence concerns the gene NFE2L3 and gastric cancer.